25 Jul 2017
A review in Annals of Internal Medicine associates cross-sex hormone therapy with increased cardiovascular risk factors among transgender men (female to male), especially among those on testosterone treatment.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024